Cervical cancer detection has witnessed significant advancements through the integration of deep learning techniques into medical imaging and diagnostic procedures. Modern deep learning methods, ...
OAK BROOK, Ill. – An artificial intelligence (AI) deep learning tool that estimates the malignancy risk of lung nodules achieved high cancer detection rates while significantly reducing false-positive ...
Early detection of lung cancer in smokers using miRNA profiles and a hybrid deep learning framework.
Results of an artificial intelligence–based tool to predict financial toxicity early to facilitate early referral to hospital social workers. This is an ASCO Meeting Abstract from the 2025 ASCO Annual ...
Researchers from the Faculty of Engineering at The University of Hong Kong (HKU) have developed two innovative deep-learning algorithms, ClairS-TO and Clair3-RNA, that significantly advance genetic ...
A deep-learning serial CT biomarker improves survival prediction in immunotherapy-treated NSCLC and outperforms RECIST. Find ...
Cancer ranks as one of the top causes of death worldwide. The National Cancer Institute reported nearly 20 million new cancer cases and 9.7 million cancer-related deaths globally in 2022, with ...
Deep learning analysis of FDG PET-CT improves survival prediction in non-metastatic breast cancer, outperforming standard staging and single modality models while supporting interpretable and ...
Long-Term Survival and Biomarker Analysis Evaluating Neoadjuvant Plus Adjuvant Relatlimab (anti-LAG3) and Nivolumab (anti-PD1) in Patients With Resectable Melanoma Our study included a broad cohort of ...
Cancer diagnoses traditionally require invasive or labor-intensive procedures such as tissue biopsies. Researchers at the Ludwig-Maximilians-Universität München (LMU) have now reported on a method ...
Five artificial intelligence (AI) technologies designed to act as a "second pair of eyes" during colonoscopies have been conditionally recommended for NHS use by the National Institute for Health and ...
MADISON, Wis., September 10, 2025 — Exact Sciences Corp. (Nasdaq: EXAS), a leader in cancer diagnostics, today announced the launch of the Cancerguard™ test, a new multi-cancer early detection (MCED) ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results